Amalgam Rx Secures $20M Credit Investment from Catalio Capital Management to Accelerate Medical-Grade AI Deployment
WILMINGTON, DE — (BUSINESS WIRE) — Amalgam Rx, Inc., a leader in enabling data-driven healthcare decision making, today announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative...
Amalgam Rx and Otsuka Precision Health, Inc (OPH) Announce AI Digital Support Solution for Caregivers of Patients with Alzheimer’s Disease
PRINCETON, N.J. and WILMINGTON, DE — (BUSINESS WIRE) — Otsuka Precision Health, Inc., (OPH), and Amalgam Rx, Inc., (Amalgam) announce the launch of ElevmiTM – an intelligent digital application that helps caregivers support loved ones with Alzheimer’s...
Amalgam’s Generative AI Platform Wins Coveted 2024 AI Breakthrough Awards
LOS ANGELES, Calif., June 26, 2024 – AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market, today announced that Amalgam Rx, Inc., a leader in enabling...
CVS Health Ventures Makes Strategic Investment in Amalgam Rx
WILMINGTON, DE — October 5, 2023 —Amalgam Rx, Inc., a leader in enabling data-driven health care decision making, announced the participation of CVS Health Ventures in its Series B investment round. The investment supports the scaling of Amalgam’s EHR-integrated...